Pennant Capital Management’s Humana HUM Stock Holding History

Pennant Capital Management’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-208,300	Closed	-$42.9M	–	46
2017 Q1	$42.9M	Buy	+208,300	New	+$43.1M	2.03%	25

Other funds holding HUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Pennant Capital Management's HUM Position: Q2 2017 in Review

Pennant Capital Management sold out of Humana (HUM) in Q2 2017, closing a stake of 208,300 shares — an estimated $42.9M sold.

Pennant Capital Management first reported a position in HUM in Q1 2017 and held it in 1 quarter. The position peaked at $42.9M in Q1 2017. 636 funds tracked by Wall St. Rank hold HUM as of Q2 2017.

Pennant Capital Management reported no remaining Humana position as of Q2 2017 after selling out during the quarter.
Pennant Capital Management sold 208,300 Humana shares in Q2 2017, an estimated $42.9M.
Pennant Capital Management first reported a position in Humana in Q1 2017 and held it in 1 quarter.
Pennant Capital Management's Humana position peaked at $42.9M in Q1 2017.
636 funds tracked by Wall St. Rank held Humana as of Q2 2017.

Based on Pennant Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.